Show/hide main menu

Maternal Hypertension

Maternal Hypertension


The Hypertension group strategy focuses on improving outcomes for women with hypertension in pregnancy through a translational approach encompassing basic science research through to clinical trials and implementation science projects. We have adopted a multi-stranded approach to the discovery and evaluation of predictive and preventative strategies for hypertension in pregnancy and its associated complications, working in the UK and in low and middle income countries to reduce adverse maternal and perinatal outcomes. This includes the following workstreams across the group.



1  Reducing maternal and fetal multi-organ complications in women with hypertension in pregnancy


Reducing adverse outcomes in women with pre-eclampsia by optimising timing of delivery


Improving antihypertensive management to improve maternal and perinatal outcomes PANDA Trial
Reducing several maternal morbidity and mortality through introduction of novel monitors in LIC settings CRADLE-2 study and CRADLE-3 trial
Optimising the monitoring and management of raised blood pressure during and after pregnancy Collaboration with the BuMP programme 

2  Improving diagnosis and prognosis in pre-eclampsia to enable targeted intervention

Investigating the links between preterm pre-eclampsia and subsequent cardiac function PHOEBE study 
Developing a prognostic test to guide timing of delivery in women with preterm delivery PEACOCK study 
Identifying women with pre-eclampsia at greatest risk through a new diagnostic test PARROT trial
Implementation of risk stratification in Brazil to reduce unnecessary preterm delivery Collaboration with the PREPARE trial 
Developing high-performing urinary diagnostic test for pre-eclampsia and superimposed pre-eclampsia PEACHES/ PAIRS study 
Understanding the structure and function of the placenta from implantation to delivery: a next generation MRI approach Collaboration with the PIP study                            

3  Implementing a new service delivery model and care pathway for women with high-risk pregnancies 

CHAMPION programme (NIHR Research Professorship together with King’s Improvement Science/ NIHR South London CLAHRC).


line_blueThe group 


 Professor Lucy Chappell                   


 Professor Andrew Shennan


Professor Jane Sandall         

Professor Lucilla Poston


 Professor Catherine Nelson-Piercy


 Professor Guillermina Girardi



Academic clinical lecturer

PhD students

Dr Louise Webster

Dr Kate Wiles

Dr Hannah Nathan

Dr Nicola Vousden

Dr Kate Duhig

Ms Rebecca Whybrow

Dr Louise Pealing (University of Oxford)

Dr Alison Ho

Technical & administrative staff

Dr Carolyn Gill

Research midwives

Ms Eleanor Hendy


Clinical Trials





A trial to determine whether planned immediate delivery, compared to expectant management, reduces maternal complications without short or longterm (neurodevelopmental) detriment to the infant.



A study to evaluate whether planned delivery improves postpartum maternal cardiac function through attenuation of myocardial ischaemia at time of disease in preterm pre-eclampsia.



A study/trial to develop and evaluate the introduction of a novel vital signs device incorporating traffic light warning system in the management of hypertension and shock in pregnancy in low-resource settings.



A study to evaluate prognostic indicators of need for delivery in women with late preterm pre-eclampsia to guide future decision making on timing of delivery.



Studies to evaluate performance of commercially available ELISAs for discriminatory proteins and validate in further cohorts and to determine whether an abnormal misfolded protein response predates clinical signs of preeclampsia and can be translated to a novel diagnostic test.



A trial to evaluate prognostic indicators of need for delivery in women with late preterm pre-eclampsia to guide future decision making on timing of delivery. 



A feasibility study for a trial comparing labetalol and nifedipine in pregnant women with chronic hypertension, including assessment of ethnic variation in drug response.


A study to develop and optimise a combined approach using advanced MR imaging, fetal ECG and detailed placental histology to provide early identification of placental and fetal compromise thereby improving outcomes.


A trial to evaluate implementation of placental growth factor measurement and fullPIERS model application to women with pre-eclampsia to enable appropriate risk stratification.


A study to develop a simple and accurate method of self-monitoring blood pressure and urine in pregnancy, to assess if self-monitoring can reduce maternal and perinatal complications from delayed diagnosis. 


A programme to evaluate the implementation of a new service delivery model and care pathway for women with hypertension in pregnancy into clinical practice.


Working with... 


KCL collaborators


External collaborators 


International collaborators


Sitemap Site help Terms and conditions  Privacy policy  Accessibility  Modern slavery statement  Contact us

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454